UKOil trades at 89.49, up 3.02% on the session.

Trend

The structure reads as above the 200-day average but with a mixed short-term picture. Price sits 3.11% above its 200-day average (86.79), 5.52% above the 20-day (84.81) and 9.20% above the 50-day (81.95). The shorter averages line up below the longer one, which reflects the near-term rebuild against a still-higher 200-day reference.

Momentum and volatility

The 14-day RSI is 58.3, a neutral reading inside the 30-70 band. The 14-day ATR is 3.37, or 3.77% of price. That volatility sits at the 61st percentile against the instrument’s own past year, so daily ranges are running a little above the twelve-month midpoint.

Range

Price sits at the 50% mark of its 52-week range, squarely in the middle. It is 25.75% below the 52-week high of 120.53, an extreme set 93 sessions ago, and 51.94% above the 52-week low of 58.90, made 206 sessions back. The last price of 89.49 sits just under the 20-day swing high of 89.57 and well above the 20-day swing low of 77.50. Zooming out, the 60-day swing high stands at 97.64 and the 60-day swing low at 70.86, so the current level is between those wider bounds.

Weekly picture

The weekly frame echoes the daily one: it reads as above the 50-week average but with a mixed short-term structure. Price is 11.02% above the 50-week average (80.61) yet 3.16% below the 20-week average (92.41), so the two weekly averages sit on opposite sides of price. The weekly RSI is 51.9, more balanced than the daily 58.3, and the last week closed up 3.02%. The timeframes agree on the longer-uptrend, above-longer-average part; the divergence is that the daily price is above its 20-day average while the weekly price is below its 20-week average.

On performance, UKOil is up 2.31% over the past week and 0.94% over the month, but down 20.79% over the quarter and up 35.25% over the past year β€” the near-term gains sit against a heavier three-month drawdown and a strongly positive twelve-month figure.

Descriptive technical summary generated by the ForexBullion Research Team from our own price feed. Not investment advice.